Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic MSCs for Dental Implant Osseointegration
NCT02731586Phase 1Unknown
- Sponsor
- Sri Sai College of Dental Surgery and Research Centre
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of allogenic mesenchymal stem cells in edentulous alveolar ridge ((none)) (2 arms), sponsored by Sri Sai College of Dental Surgery and Research Centre. Primary endpoint: Implant Stability Quotient at 12 weeks. Status: unknown.
02
Drugs
allogenic mesenchymal stem cells
03
Conditions
edentulous alveolar ridge ((none))
Beyond the preview
Go deeper on NCT02731586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02731586.